Delcath Systems, Inc. (DCTH)
USD 10.96
(-8.21%)
USD 10.96
(-8.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.43 Million USD | -35.96% |
| 2022 | 2.03 Million USD | -29.51% |
| 2021 | 2.88 Million USD | 186.68% |
| 2020 | 1 Million USD | 16.84% |
| 2019 | 861 Thousand USD | -64.1% |
| 2018 | 2.39 Million USD | 19.07% |
| 2017 | 2.01 Million USD | 39.67% |
| 2016 | 1.44 Million USD | 12.22% |
| 2015 | 1.28 Million USD | 65.17% |
| 2014 | 778 Thousand USD | 138.65% |
| 2013 | 326 Thousand USD | 6.19% |
| 2012 | 307 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 6.24 Million USD | 179.38% |
| 2024 Q1 | 2.23 Million USD | 583.79% |
| 2023 Q3 | 301 Thousand USD | -12.75% |
| 2023 FY | 1.3 Million USD | -35.96% |
| 2023 Q2 | 345 Thousand USD | -17.07% |
| 2023 Q1 | 416 Thousand USD | 3.48% |
| 2023 Q4 | 327 Thousand USD | 8.64% |
| 2022 Q3 | 671 Thousand USD | 8.75% |
| 2022 Q1 | 345 Thousand USD | -82.56% |
| 2022 Q2 | 617 Thousand USD | 78.84% |
| 2022 Q4 | 402 Thousand USD | -40.09% |
| 2022 FY | 2.03 Million USD | -29.51% |
| 2021 FY | 2.88 Million USD | 186.68% |
| 2021 Q4 | 1.97 Million USD | 570.51% |
| 2021 Q3 | 295 Thousand USD | -11.68% |
| 2021 Q2 | 334 Thousand USD | 21.01% |
| 2021 Q1 | 276 Thousand USD | -8.31% |
| 2020 Q4 | 301 Thousand USD | 8.27% |
| 2020 Q3 | 278 Thousand USD | 31.75% |
| 2020 Q1 | 216 Thousand USD | -9.24% |
| 2020 Q2 | 211 Thousand USD | -2.31% |
| 2020 FY | 1 Million USD | 16.84% |
| 2019 Q2 | 240 Thousand USD | 37.93% |
| 2019 FY | 861 Thousand USD | -64.1% |
| 2019 Q4 | 238 Thousand USD | 14.42% |
| 2019 Q3 | 208 Thousand USD | -13.33% |
| 2019 Q1 | 174 Thousand USD | -71.66% |
| 2018 FY | 2.39 Million USD | 19.07% |
| 2018 Q2 | 638 Thousand USD | 14.95% |
| 2018 Q3 | 591 Thousand USD | -7.37% |
| 2018 Q4 | 614 Thousand USD | 3.89% |
| 2018 Q1 | 555 Thousand USD | 4.72% |
| 2017 Q4 | 530 Thousand USD | 3.52% |
| 2017 Q3 | 512 Thousand USD | 14.03% |
| 2017 Q2 | 449 Thousand USD | -14.31% |
| 2017 Q1 | 524 Thousand USD | 5.01% |
| 2017 FY | 2.01 Million USD | 39.67% |
| 2016 Q1 | 259 Thousand USD | -23.15% |
| 2016 Q3 | 323 Thousand USD | -10.53% |
| 2016 Q2 | 361 Thousand USD | 39.38% |
| 2016 FY | 1.44 Million USD | 12.22% |
| 2016 Q4 | 499 Thousand USD | 54.49% |
| 2015 FY | 1.28 Million USD | 65.17% |
| 2015 Q3 | 309 Thousand USD | -6.08% |
| 2015 Q1 | 311 Thousand USD | 48.1% |
| 2015 Q4 | 337 Thousand USD | 9.06% |
| 2015 Q2 | 329 Thousand USD | 5.79% |
| 2014 FY | 778 Thousand USD | 138.65% |
| 2014 Q2 | 185 Thousand USD | -14.75% |
| 2014 Q1 | 217 Thousand USD | -16.54% |
| 2014 Q4 | 210 Thousand USD | 25.75% |
| 2014 Q3 | 167 Thousand USD | -9.73% |
| 2013 Q2 | -332 Thousand USD | -194.86% |
| 2013 FY | 326 Thousand USD | 6.19% |
| 2013 Q4 | 260 Thousand USD | 430.61% |
| 2013 Q3 | 49 Thousand USD | 114.76% |
| 2013 Q1 | 350 Thousand USD | 117.39% |
| 2012 FY | 307 Thousand USD | 0.0% |
| 2012 Q4 | 161 Thousand USD | 312.82% |
| 2012 Q1 | - USD | 100.0% |
| 2012 Q2 | 106 Thousand USD | 0.0% |
| 2012 Q3 | 39 Thousand USD | -63.21% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 100.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | -46.45 Million USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | -30.74 Billion USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 100.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | -8.06 Billion USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | -6.91 Billion USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q2 | -423.77 Thousand USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 100.0% |
| 2001 Q3 | - USD | 100.0% |
| 2001 Q2 | -553.43 Thousand USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accuray Incorporated | 142.92 Million USD | 98.999% |
| Envoy Medical, Inc. | -473 Thousand USD | 402.326% |
| Xylo Technologies Ltd. | 11.84 Million USD | 87.923% |